Gut microbial composition difference between pediatric ALL survivors and siblings

References

• Tai EW, Ward KC, Bonaventure A, Siegel DA, Coleman MP. Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: findings from the CONCORD-2 study. Cancer. 2017;123(Suppl 24):5178–5189. doi:10.1002/cncr.30899.
   PubMedGoogle Scholar
• Noone AM, Howlader N, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2015. Bethesda, MD: National Cancer Institute.
   Google Scholar
• Mariotto AB, Rowland JH, Yabroff KR, et al. Long-term survivors of childhood cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1033–1040. doi:10.1158/1055-9965.EPI-08-0988.
   PubMed Web of Science ®Google Scholar
• Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14(1):61–70. doi:10.1038/nrc3634.
   PubMed Web of Science ®Google Scholar
• Hudson MM, Oeffinger KC, Jones K, et al. Age-dependent changes in health status in the Childhood Cancer Survivor cohort. J Clin Oncol. 2015;33(5):479–491. doi:10.1200/JCO.2014.57.4863.
   PubMed Web of Science ®Google Scholar
• Essig S, Li Q, Chen Y, et al. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2014;15(8):841–851. doi:10.1016/S1470-2045(14)70265-7.
   PubMed Web of Science ®Google Scholar
• Brown AL, Lupo PJ, Danysh HE, et al. Prevalence and predictors of overweight and obesity among a multiethnic population of pediatric acute lymphoblastic leukemia survivors: a cross-sectional assessment. J Pediatr Hematol Oncol. 2016;38(6):429–436. doi:10.1097/MPH.0000000000000555.
   PubMed Web of Science ®Google Scholar
• Wilson CL, Liu W, Yang JJ, et al. Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: a report from the St. Jude lifetime cohort. Cancer. 2015;121(13):2262–2270. doi:10.1002/cncr.29153.
   PubMed Web of Science ®Google Scholar
• Zhang FF, Kelly MJ, Saltzman E, Must A, Roberts SB, Parsons SK. Obesity in pediatric ALL survivors: a meta-analysis. Pediatrics. 2014;133(3):e704–15. doi:10.1542/peds.2013-3332.
   PubMed Web of Science ®Google Scholar
• Saultier P, Auquier P, Bertrand Y, et al. Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: An L.E.A. study. Haematologica. 2016;101(12):1603–1610. doi:10.3324/haematol.2016.148908.
   PubMed Web of Science ®Google Scholar
• Barnea D, Raghunathan N, Friedman DN, Tonorezos ES. Obesity and metabolic disease after childhood cancer. Oncology. 2015; 29(11):849–855.
   PubMed Web of Science ®Google Scholar
• Nottage KA, Ness KK, Li C, Srivastava D, Robison LL, Hudson MM. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - from the St. Jude lifetime cohort. Br J Haematol. 2014;165(3):364–374. doi:10.1111/bjh.12754.
   PubMed Web of Science ®Google Scholar
• Chen MH, Colan SD, Diller L. Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res. 2011;108(5):619–628. doi:10.1161/CIRCRESAHA.110.224519.
   PubMed Web of Science ®Google Scholar
• Mulrooney DA, Hyun G, Ness KK, et al. The changing burden of late health outcomes in adult survivors of childhood acute lymphoblastic leukaemia: a report from the St Jude Lifetime Cohort Study. Lancet Haematol. 2019;6(6):e306–e316. doi:10.1016/S2352-3026(19)30050-X.
   PubMed Web of Science ®Google Scholar
• Ariffin H. Challenges in surviving childhood leukaemia. Lancet Haematol. 2019;6(6):e288–e289. doi:10.1016/S2352-3026(19)30047-X.
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157(1):121–141. doi:10.1016/j.cell.2014.03.011.
   PubMed Web of Science ®Google Scholar
• Kho ZY, Lai SK. The human gut microbiome - a potential controller of wellness and disease. Frontiers Microbiol. 2018;9:1–23.
   PubMed Web of Science ®Google Scholar
• Ihekweazu FD, Versalovic J. Development of the pediatric gut microbiome: impact on health and disease. Am J Med Sci. 2018;356(5):413–423. doi:10.1016/j.amjms.2018.08.005.
   PubMed Web of Science ®Google Scholar
• Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ. Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis. 2015;26:26191. doi:10.3402/mehd.v26.26191.
   PubMed Web of Science ®Google Scholar
• Le Chatelier E, Nielsen J, Qin E, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541–546. doi:10.1038/nature12506.
   PubMed Web of Science ®Google Scholar
• Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101(44):15718–15723. doi:10.1073/pnas.0407076101.
   PubMed Web of Science ®Google Scholar
• Davis CD. The gut microbiome and its role in obesity. Nutr Today. 2016;51(4):167–174. doi:10.1097/NT.0000000000000167.
   PubMedGoogle Scholar
• Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005;102 (31):11070–11075. doi:10.1073/pnas.0504978102. Erratum in: Cell Metab. 2016 Mar 8;23(3):564–6
   PubMed Web of Science ®Google Scholar
• Ussar S, Griffin NW, Bezy O, et al. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab. 2015;22(3):526–530.
   Web of Science ®Google Scholar
• Riva A, Borgo F, Lassandro C, et al. Pediatric obesity is associated with an altered gut microbiota and discordant shifts in firmicutes populations. Environ Microbiol. 2017;19(1):95–105. doi:10.1111/1462-2920.13463.
   PubMed Web of Science ®Google Scholar
• Kalliomäki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008;87(3):534–538. doi:10.1093/ajcn/87.3.534.
   PubMed Web of Science ®Google Scholar
• Gao X, Jia R, Xie L, et al. Obesity in school-aged children and its correlation with gut E.coli and bifidobacteria: a case- control study. BMC Pediatr. 2015;15(1):64. doi:10.1186/s12887-015-0384-x.
   PubMedGoogle Scholar
• Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480–484. doi:10.1038/nature07540.
   PubMed Web of Science ®Google Scholar
• Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341(6150):1241214. doi:10.1126/science.1241214.
   PubMed Web of Science ®Google Scholar
• Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17(5):271–285. doi:10.1038/nrc.2017.13.
   PubMed Web of Science ®Google Scholar
• Bhuta R, Nieder M, Jubelirer T, Ladas EJ. The gut microbiome and pediatric cancer: current research and gaps in knowledge. J Natl Cancer Inst Monogr. 2019;2019(54):169–173. doi:10.1093/jncimonographs/lgz026.
   PubMedGoogle Scholar
• Wen Y, Jin R, Chen H. Interactions between gut microbiota and acute childhood leukemia. Front Microbiol. 2019;10:1300. doi:10.3389/fmicb.2019.01300. eCollection 2019.
   PubMed Web of Science ®Google Scholar
• Fijlstra M, Ferdous M, Koning AM, Rings E, Harmsen HJM, Tissing WJE. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support Care Cancer. 2015;23(6):1513–1522. doi:10.1007/s00520-014-2487-6.
   PubMed Web of Science ®Google Scholar
• Montassier E, Gastinne T, Vangay P, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42(5):515–528. doi:10.1111/apt.13302.
   PubMed Web of Science ®Google Scholar
• Abeles SR, Jones MB, Santiago-Rodriguez TM, et al. Microbial diversity in individuals and their household contacts following typical antibiotic courses. Microbiome. 2016;4(1):39. doi:10.1186/s40168-016-0187-9.
   PubMed Web of Science ®Google Scholar
• Khosravi A, Yáñez A, Price JG, et al. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe. 2014;15(3):374–381. doi:10.1016/j.chom.2014.02.006.
   PubMed Web of Science ®Google Scholar
• Bai L, Zhou P, Li D, Ju X. Changes in the gastrointestinal microbiota of children with acute lymphoblastic leukaemia and its association with antibiotics in the short term. J Med Microbiol. 2017. doi:10.1099/jmm.0.000568.
   PubMed Web of Science ®Google Scholar
• Zwielehner J, Lassl C, Hippe B, et al. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One. 2011;6(12):e28654. doi:10.1371/journal.pone.0028654.
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by Deep16S rRNA sequencing. PLoS Biol. 2008;6(11):2383–2400. doi:10.1371/journal.pbio.0060280.
   Web of Science ®Google Scholar
• Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA. 2011;108(Supplement_1):4554–4561. doi:10.1073/pnas.1000087107.
   PubMed Web of Science ®Google Scholar
• Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. Isme J. 2007;1(1):56–66. doi:10.1038/ismej.2007.3.
   PubMed Web of Science ®Google Scholar
• Galloway-Peña JR, Smith DP, Sahasrabhojane P, et al. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. 2016;122(14):2186–2196. doi:10.1002/cncr.30039.
   PubMed Web of Science ®Google Scholar
• Van Vliet MJ, Tissing WJE, Dun CAJ, et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis. 2009;49(2):262–270. doi:10.1086/599346.
   PubMed Web of Science ®Google Scholar
• Rajagopala SV, Yooseph S, Harkins DM, et al. Gastrointestinal microbial populations can distinguish pediatric and adolescent acute lymphoblastic leukemia (ALL) at the time of disease diagnosis. BMC Genomics. 2016;17(1):635. doi:10.1186/s12864-016-2965-y.
   PubMedGoogle Scholar
• Hakim H, Dallas R, Wolf J, et al. Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clin Infect Dis. 2018;67(4):541–548. doi:10.1093/cid/ciy153.
   PubMed Web of Science ®Google Scholar
• Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222–227. doi:10.1038/nature11053.
   PubMed Web of Science ®Google Scholar
• Wong WSW, Clemency N, Klein E, et al. Collection of non-meconium stool on fecal occult blood cards is an effective method for fecal microbiota studies in infants. Microbiome. 2017;5(1):11.
   PubMedGoogle Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336.
   PubMed Web of Science ®Google Scholar
• Bokulich NA, Subramanian S, Faith JJ, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon. Nat Methods. 2013;10(1):57–59.
   PubMed Web of Science ®Google Scholar
• McDonald D, Price MN, Goodrich J, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6(3):610–618.
   PubMed Web of Science ®Google Scholar
• Lê Cao KA, Boitard S, Besse P. Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems. BMC Bioinf. 2011;12(1):253.
   PubMedGoogle Scholar
• Chua LL, Rajasuriar R, Azanan MS, et al. Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome. 2017;5(1):35. doi:10.1186/s40168-017-0250-1.
   PubMedGoogle Scholar
• Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics ad prognostics. ISME J. 2017;11(4):841–852.
   PubMed Web of Science ®Google Scholar
• Biagi E, Zama D, Nastasi C, et al. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant. 2015;50(7):992–998. doi:10.1038/bmt.2015.16.
   PubMed Web of Science ®Google Scholar
• Miquel S, Martín R, Rossi O, et al. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2013;16(3):255–261. doi:10.1016/j.mib.2013.06.003.
   PubMed Web of Science ®Google Scholar
• Zhou L, Zhang M, Wang Y, et al. Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm Bowel Dis. 2018.
   Web of Science ®Google Scholar
• Chen X, Devaraj S. Gut microbiome in obesity, metabolic syndrome, and diabetes. Curr Diab Rep. 2018;18(12):129. Review. PubMed PMID: 30338410 doi:10.1007/s11892-018-1104-3.
   PubMed Web of Science ®Google Scholar
• Mazidi M, Rezaie P, Kengne AP, Mobarhan MG, Ferns GA. Gut microbiome and metabolic syndrome. Diabetes Metab Syndr. 2016;10(2):S150–S137. doi:10.1016/j.dsx.2016.01.024.
   PubMed Web of Science ®Google Scholar
• Cox LM, Yamanishi S, Sohn J, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158(4):705–721.
   PubMed Web of Science ®Google Scholar
• Nearing JT, Connors J, Whitehouse S, et al. Infectious complications are associated with alterations in the gut microbiome in pediatric patients with acute lymphoblastic leukemia. Front Cell Infect Microbiol. 2019;9:28. doi:10.3389/fcimb.2019.00028.
   PubMed Web of Science ®Google Scholar
• Hilton SK, Castro-Nallar E, Pérez-Losada M, et al. Metataxonomic and metagenomic approaches vs. culture-based techniques for clinical pathology. Front Microbiol. 2016;7:484. doi:10.3389/fmicb.2016.00484.
   PubMed Web of Science ®Google Scholar
• Rajagopala SV, Singh H, Yu Y, et al. Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (ALL) during chemotherapy. Microb Ecol. 2019;79:1034–1043. doi:10.1007/s00248-019-01448-x.
   PubMed Web of Science ®Google Scholar